Vascular BioSciences Board of Advisors

Samuel Z. Goldhaber, M.D., Associate Professor of Cardiovascular Medicine, Peter Bent Brigham Hospital, Harvard Medical School, in Boston, Massachusetts, is an internationally recognized expert in vascular diseases. Director, Anticoagulation Service, and Director, Venous Thromboembolism Research Group at Brigham and Women's Hospital, Dr. Goldhaber's clinical interests include pulmonary embolism, general clinical cardiology, coronary artery disease, peripheral vascular disease, atrial fibrillation, anticoagulation treatment, chronic venous insufficiency and thrombolstic therapy. Timothy Morris, M.D., Assistant Professor of Medicine, Department of Pulmonary and Critical Care Medicine, University of California San Diego Medical Center in San Diego, California, is a recognized expert in the diagnosis of thromboembolic disease. Dr. Morris' clinical interests include general pulmonary medicine, acute pulmonary thromboembolic disease and critical care. Erkki Ruoslahti, M.D., Ph.D., Distinguished Professor at The Burnham Institute, La Jolla, California. Dr. Ruoslahti is an internationally recognized scientist in the areas of vascular targeting peptide technology, vascular biology, cell adhesion, and tumor biology.  Dr. Ruoslahti served as the President of The Burnham Institute from 1989 to 2001, has published more than 400 scientific papers, and is the inventor of more than 150 patents. His inventions form the basis of two clinically used drugs as well as several that are under development. He has co-founded several biotech companies and has served as a director or advisory board member of these and other companies. He has been awarded numerous prizes for scientific accomplishment, and was a Nobel fellow at the Karolinska Institute in Stockholm, Sweden. Dr. Ruoslahti is a member of the U.S. National Academy of Sciences and the Institute of Medicine. David Warburton, M.D., F.R.C.P., Professor of Pediatrics, University of Southern California School of Medicine, Director, Developmental Biology Program, Children's Hospital Los Angeles Research Institute in Los Angeles, California, is a recognized expert in developmental biology. Dr. Warburton's research interests include molecular embryology, stem cell biology, lung development and lung morphogenesis.